Asparawem 5000IU Injection

Asparawem 5000IU Injection

Prescription requiredRx Required

Salt Composition: L- Asparaginase

Expiry Date: 01/2028

Special offer

Buy at $23.82

$23.82

Inclusive of all taxes

1 vial(s)5

About The Product

lymphoblastic leukemia

Description

Asparawem 500IU Injection is an anti-cancer medication. It is used in the treatment of lymphoblastic leukemia by breaking down the amino acid asparagine.

Through which cancerous lymphoblast cannot produce on their own, they stopping their growth. The medication active ingredient is L- Asparaginase, an enzyme that specifically hydrolyzes asparagine into aspartic acid and ammonia, leading to cancer cell growth.

The medication should be taken under strict medical supervision. Avoid taking this medication under the age of 18.

Uses

Lymphoblastic leukemia

Common side effects

  • Asparawem 500IU Injection may cause side effects like any other medication have, consult the doctor before taking the medication to ensure safety and effectiveness of the treatment.
  • Here are some common side effects: ● Nausea ● Muscle pain ● Weight loss ● Infections (fever, rapid heart rate, confusion, or a rash) ● Difficulty breathing ● Inflammation of the digestive tract ● High blood sugar levels ● Bleeding ● Liver and nervous problems ● Pain near your stomach (inflammation of the pancreas) ● Blood clots in arm or leg

How to use

  • Asparawen 500IU injection can be taken with or without food.
  • Take the medication with a whole glass of water.
  • Do not skip or stop the medicine without consultation from a healthcare provider.
  • It should always be administered under medical supervision and dosage or schedule must be followed exactly to avoid complications.

How it works

In acute lymphoblastic leukemia, the white blood cells called lymphocytes multiplied in uncontrolled manner. Asparaginase is an enzyme that interferes with natural processes necessary for cancer cell growth, thereby killing or stopping the cancer cell growth.

Thereby it killing or stopping the growth of tumors in the body. Doctor's use this medication as a primary source of blood cancer.

Safety advice

Alcohol
Alcohol is strictly prohibited during blood cancer treatment. Doctors do not recommend to take alcohol while taking Asparawen 500IU injection.
Driving
It is unknown that the Asparawen 500IU injection caused dizziness but in case if you experience sleepiness then avoid driving and working on machinery while taking the medication.
Pregnancy
Asparawen 500IU injection is not prescribed for pregnant woman as it may harm the fetus because of its high potency, and therefore should only be used under strict medical supervision.
Breast Feeding
Women who breastfeed should avoid using Asparawen 500IU injection because the medication is passed through the breast which harm the baby in many ways.
Kidney
Asparawen 500IU injection is not recommended to kidney patient because it may interfere with the kidney function treatment.
Liver
Asparawen 500IU injection is not prescribed to liver patient with severe liver problems because impaired liver function can affect how the medicine is processed in the body.

FAQs

Asparawen 500IU injection is taken by the patient of blood cancer by allowing the enzyme L- Asparaginase to enter the blood stream and deplete asparagine which stops the growth of leukemia cells.

Reference

• Batool, T., Makky, E. A., Jalal, M., & Yusoff, M.

M. (2016).

A comprehensive review on L-asparaginase and its applications. Applied biochemistry and biotechnology, 178(5), 900-927. • Keating, M.

J., Holmes, R., Lerner, S., & Ho, D. H.

(1993). L-asparaginase and PEG asparaginase—past, present, and future.

Leukemia & lymphoma, 10(sup1), 153-157. • Müller, H. J., & Boos, J.

(1998). Use of L-asparaginase in childhood ALL.

Critical reviews in oncology/hematology, 28(2), 97-113. • Verma, N., Kumar, K., Kaur, G., & Anand, S. (2007).

L-asparaginase: a promising chemotherapeutic agent. Critical reviews in biotechnology, 27(1), 45-62. • Whitecar Jr, J.

P., Bodey, G. P., Harris, J.

E., & Freireich, E. J.

(1970). L-asparaginase.

New England Journal of Medicine, 282(13), 732-734.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026